ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print October 1, 2008
Eur Respir J 2008, doi:10.1183/09031936.00093408
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Supplementary methods and results
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Jolley, C.J.
Right arrow Articles by Moxham, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jolley, C.J.
Right arrow Articles by Moxham, J.


ORIGINAL ARTICLE

Neural respiratory drive in healthy subjects and in chronic obstructive pulmonary disease

C.J. Jolley 1*, Y-M. Luo 2, J. Steier 1, C. Reilly 1, J. Seymour 1, A. Lunt 1, K. Ward 1, G.F. Rafferty 1, M. I Polkey 3, J. Moxham 1

1 King's College London School of Medicine, King's College Hospital
2 Guangzhou Institute of Respiratory Diseases, Guangzhou Medical College, State Key Laboratory of Respiratory Disease, Guangzhou, China
3 Royal Brompton Hospital, London, UK

* To whom correspondence should be addressed. E-mail: caroline.jolley{at}kcl.ac.uk.


   Abstract

We aimed to use the diaphragm electromyogram (EMGdi) to compare levels of neural respiratory drive (NRD) in a cohort of healthy subjects and COPD patients, and to investigate the relationship between NRD and pulmonary function in COPD.

EMGdi was recorded at rest and normalised to peak EMGdi recorded during maximum inspiratory manoeuvres (EMGdi%max) in 100 healthy subjects and 30 patients with COPD, using a multipair oesophageal electrode. EMGdi was normalised to the amplitude of the diaphragm compound muscle action potential (CMAPdiMS) in 64 healthy subjects.

EMGdi%max was 9.0 (3.4)% in healthy subjects and 27.9 (9.9)% in COPD (p<0.001), and correlated with %predicted FEV1 (r2=0.40, p<0.001), VC (r2=0.61, p<0.001), and inspiratory capacity (r2=0.28, p=0.02) in patients. EMGdi%max was higher in healthy 51–80 year olds than 18–50 year olds (11.4 (3.4) vs 8.2 (2.9) %, p<0.001). Observations in the healthy group were similar when peak EMGdi or CMAPdiMS were used to normalise EMGdi.

Levels of NRD were higher in COPD than healthy subjects, and related to disease severity. CMAPdiMS could be used to normalise EMGdi if volitional inspiratory manoeuvres cannot be performed, allowing translation of the technique to critically-ill and ventilated patients.

Keywords:  Chronic obstructive pulmonary disease, electromyography, respiratory diaphragm







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the European Respiratory Society.